Validea's Top Information Technology Stocks Based On Warren Buffett

Validea's Patient Investor model, based on Warren Buffett's strategy for long-term predictable profitability and reasonable valuations, has strongly endorsed Lam Research Corp (LRCX) with a 100% rating, citing its robust fundamentals and valuation as a semiconductor equipment supplier. Conversely, EPAM Systems Inc (EPAM), a digital engineering firm, received a 72% rating, falling below the model's 'some interest' threshold primarily due to its expected return.

Analysis

Based on Validea's 'Patient Investor' model, which emulates Warren Buffett's investment principles, Lam Research Corp (LRCX) presents a highly compelling investment case. The large-cap semiconductor equipment supplier achieved a perfect 100% rating, signifying strong interest from the strategy. This top score is underpinned by LRCX passing all nine of the model's rigorous tests, including earnings predictability, low debt service, high return on equity, and robust free cash flow. The model also positively flags the company's use of retained earnings and share repurchase activity, confirming a shareholder-friendly capital allocation policy. In contrast, EPAM Systems Inc (EPAM), a mid-cap digital engineering firm, received a 72% rating, placing it below the 80% threshold for 'some interest.' While EPAM demonstrated strength by passing eight fundamental criteria such as return on total capital and debt service, its failure on the 'EXPECTED RETURN' metric is a critical disqualifier. This indicates that, despite its operational soundness, EPAM's current stock valuation does not meet the model's criteria for providing a sufficient long-term rate of return, highlighting the strategy's dual focus on both company quality and attractive pricing.

Key Decisions for Investors

• Investors aligned with a long-term, value-oriented strategy should view Lam Research (LRCX) as a high-conviction candidate, given its perfect 100% score based on strong fundamentals and a favorable valuation according to the model.
• The analysis of EPAM Systems (EPAM) suggests caution; its failure on the 'expected return' metric indicates that its current valuation may not offer an adequate margin of safety, despite its otherwise strong fundamental profile.
• Investors should note the critical importance of valuation in this strategy, as the divergence between LRCX's top rating and EPAM's sub-par score is driven solely by the expected return on investment at current prices.